Zura Bio Financials
| ZURA Stock | 3.05 0.05 1.67% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.72 | 4.9671 |
|
|
Investors should never underestimate Zura Bio's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Zura Bio's cash flow, debt, and profitability to make informed and accurate decisions about investing in Zura Bio Limited.
Net Income |
|
Zura |
Understanding current and past Zura Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Zura Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Zura Bio's assets may result in an increase in income on the income statement.
Please note, the presentation of Zura Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zura Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zura Bio's management manipulating its earnings.
Zura Bio Stock Summary
Zura Bio competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. Zura Bio is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | KYG9TY5A1016 |
| CUSIP | G9TY5A101 G50752107 |
| Location | California; U.S.A |
| Business Address | 1489 W Warm |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | zurabio.com |
| Phone | 702 757 6133 |
Zura Bio Key Financial Ratios
| Return On Equity | -0.37 | ||||
| EBITDA | (60.56 M) | ||||
| Net Income | (60.56 M) | ||||
| Book Value Per Share | 2.34 X | ||||
| Market Capitalization | 295.78 M |
Zura Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zura Bio's current stock value. Our valuation model uses many indicators to compare Zura Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zura Bio competition to find correlations between indicators driving Zura Bio's intrinsic value. More Info.Zura Bio Limited is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . At present, Zura Bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zura Bio's earnings, one of the primary drivers of an investment's value.Zura Bio Limited Systematic Risk
Zura Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Zura Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Zura Bio Limited correlated with the market. If Beta is less than 0 Zura Bio generally moves in the opposite direction as compared to the market. If Zura Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Zura Bio Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Zura Bio is generally in the same direction as the market. If Beta > 1 Zura Bio moves generally in the same direction as, but more than the movement of the benchmark.
Zura Bio November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Zura Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Zura Bio Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Zura Bio Limited based on widely used predictive technical indicators. In general, we focus on analyzing Zura Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Zura Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 26.7 | |||
| Value At Risk | (7.94) | |||
| Potential Upside | 7.95 |
Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |